Lung adenocarcinoma rewires circadian transcription and metabolism in the liver
This rewiring involves the STAT3-Socs3 inflammatory signaling axis
Inhibition of hepatic insulin signaling and glucose intolerance are tumor driven
Lung adenocarcinoma drives deregulation of lipid metabolism in the liver